Use of Various Laser Systems in Peri-implatit

Effect of Various Laser Systems in Smokers and Nonsmokers With Peri-implantitis: A Randomized, Prospective, Single-Blind Clinical Trial

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT04826783

Enrollment

Registered

2021-04-01

Start date

2021-04-25

Completion date

2022-04-25

Last updated

2021-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peri-Implantitis

Brief summary

Objectives: In recent years, a new field of work has been created with the use of laser beam to provide titanium surface decontamination. The aim of this study was to evaluate the effect of various laser systems in smokers and non-smokers with peri-implantitis. Materials and Methods: According to the study protocol, patients, who were diagnosed with peri-implantitis based on the clinical and radiographic evaluations, were divided into six groups: Group 1: smokers undergoing diode laser application; Group 2: smokers undergoing Erbium, chromium: yttrium, scandium, gallium, garnet (Er, Cr:YSGG) laser application; Group 3: smokers undergoing Erbium:yttrium-aluminum-garnet (Er:YAG) laser application; Group 4: non-smokers undergoing diode laser application; Group 5: non-smokers undergoing Er, Cr:YSGG laser application; and Group 6: non-smokers undergoing Er:YAG laser application. Peri-implant sulcus depth (SD), clinical attachment level (CAL), suppuration, modified plaque index (mPI), gingival index (GI), and modified sulcus bleeding index (mSBI) were recorded and peri-implant sulcus fluid (PISF) was collected to evaluate osteocalcin.

Interventions

DEVICELasers

The laser tip was applied as vertical and horizontal scan along the subgingival implant . The procedure was carried out on day zero, seven and 14.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

SINGLE (Subject)

Eligibility

Sex/Gender

ALL

Age

30 Years to 60 Years

Healthy volunteers

Inclusion criteria

1. Presence of pocket in probing depth of ≥4 mm in at least one implant 2. No mobility in implant 3. Implants with bridge foot and opposite occlusion 4. Having no systemic disease that may affect the outcome of treatment 5. No systemic use of antibiotics for the last six months 6. Not receiving peri-implantitis treatment for the last three months 7. Individuals at the 30-60 years of age.

Exclusion criteria

1. Individuals who did not agree to participate in the study 2. Individuals receiving radiation therapy 3. Individuals using alcohol 4. Presence of pregnancy and lactation period 5. Individuals with parafunctional habits such as clenching or bruxism.

Design outcomes

Primary

Measure	Time frame
Sulcus depth	basaline - six month

Countries

Turkey (Türkiye)

Contacts

Primary Contactkubilay barış

dt.bkubilay@gmail.com05539736477

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026